This internal suppression mechanism, driven by both chronic inflammasome activation and insulin-mediated regulation, may help explain why PCOS samples showed lower NLRP3 expression compared to some control individuals, who might have experienced more acute or unregulated inflammatory signals. This evidence concerns the gene NLRP3 and polycystic ovary syndrome.